Re: ZHCLF

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2655 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: ZHCLF

in response to

Re: ZHCLF

jonzobot

posted on Jan 30, 2024 04:37PM

For a company that is virtual invisible to the investment community other than those invested in RVX that 2nd day volume of 170k is significant. I often wonder why anyone would take part in a Zenith PP at .80 cents when you can those same shares at .12 cents USD. If the rumours of a pending royalty deal are true than I guess .12 cents is a steal at some point.

4 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply